Diebold, Inc. (DBD) Tops Q2 EPS by 13c, Reaffirms FY11 Guidance
Tweet
Share
E-mailGet Alerts DBD Hot Sheet
Price: $68.67 +0.70%
Financial Fact:
Income (loss) from discontinued operations: 0.01
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Income (loss) from discontinued operations: 0.01
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold, Inc. (NYSE: DBD) reported Q2 EPS of $0.44, $0.13 better than the analyst estimate of $0.31. Revenue for the quarter came in at $662.4 million versus the consensus estimate of $655.93 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
- Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
